e-learning
resources
Glasgow 2004
Monday 06.09.2004
COPD: prevalence and risk factors
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Chronic obstructive pulmonary disease in 55 years old women from Germany according to GOLD stages
U. Kraemer, V. Reimann, D. Sugiri, B. Pesch (Düsseldorf, Bochum, Germany)
Source:
Annual Congress 2004 - COPD: prevalence and risk factors
Session:
COPD: prevalence and risk factors
Session type:
Thematic Poster Session
Number:
2248
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
U. Kraemer, V. Reimann, D. Sugiri, B. Pesch (Düsseldorf, Bochum, Germany). Chronic obstructive pulmonary disease in 55 years old women from Germany according to GOLD stages. Eur Respir J 2004; 24: Suppl. 48, 2248
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Related content which might interest you:
Markers of bone metabolism in men with chronic obstructive pulmonary disease (COPD) aged 40-70 years
Source: International Congress 2014 – Comorbidities
Year: 2014
Mild chronic obstructive pulmonary disease in smokers over the age of 30
Source: International Congress 2019 – Challenges in tobacco control and cessation
Year: 2019
Relation of various parameters to the survival rate in stage 0 to stage IIa chronic obstructive pulmonary disease (COPD) according to the GOLD guidelines
Source: Eur Respir J 2003; 22: Suppl. 45, 578s
Year: 2003
Model of staged development chronic obstructive pulmonary disease (COPD) in rats
Source: Annual Congress 2011 - Novel mechanisms in lung injury
Year: 2011
Prevalence of chronic obstructive pulmonary disease(COPD) in population aged 40-69 in Konak-Izmir-Turkey
Source: Eur Respir J 2004; 24: Suppl. 48, 359s
Year: 2004
Five years outcome of Karakoca Resector Balloon dilalation and curetage method in Severe COPD (chronic obstructive pulmonary disease )
Source: International Congress 2018 – Endoscopic lung volume reduction
Year: 2018
Anemia in COPD patients of Korean obstructive lung disease (KOLD) cohort
Source: International Congress 2015 – Multidimensional analysis of respiratory problems
Year: 2015
Chronic obstructive pulmonary disease (COPD) in children: is it possible?
Source: Eur Respir J 2005; 26: Suppl. 49, 63s
Year: 2005
Functional surgery for chronic obstructive pulmonary disease: a single centre 30 years‘ experience
Source: Eur Respir J 2005; 26: Suppl. 49, 490s
Year: 2005
Treatment patterns of patients with chronic obstructive pulmonary disease (COPD) in Ontario, Canada
Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data
Year: 2021
Dietary habits in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –The latest insights in respiratory muscles, neuromuscular disease and comorbidities
Year: 2013
Predictors of health status in chronic obstructive pulmonary disease patients over three years
Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease
Year: 2009
Prediction of mortality in the Swiss chronic obstructive pulmonary disease (COPD) cohort using the age dyspnoe and airflow obstruction index (ADO)
Source: Annual Congress 2012 - Diagnostic insights and decision making in primary care
Year: 2012
Prevalence of chronic obstructive pulmonary disease (COPD) in a general population in Norway
Source: Annual Congress 2012 - COPD epidemiology
Year: 2012
Prevalence of symptoms of chronic obstructive pulmonary disease among different gender and age groups according to the survey
Source: International Congress 2017 – Highlights on clinical problems in COPD
Year: 2017
Population health impact of Indacaterol/Glycopyrronium over 4 years in chronic obstructive pulmonary disease
Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet?
Year: 2018
Prevalence of chronic obstructive pulmonary disease (COPD) in Greece
Source: Eur Respir J 2002; 20: Suppl. 38, 122s
Year: 2002
Awareness of chronic obstructive pulmonary disease (COPD) in Portugal
Source: Eur Respir J 2007; 30: Suppl. 51, 126s
Year: 2007
Does Nutritional Risk Screening 2002 correlate with dyspnea status of patients with GOLD stage 3-4 chronic obstructive pulmonary disease: a Cohort study.
Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept